4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-028839
CBO & COO sold 25,000 shares at an average $60.40 ($1,509,971)
- CBO & COO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klein Lawrence Otto CBO & COO | 2020-05-11 | Option exercise | +25,000 | $5.86 | $146,500 | 45,000 | D |
| Klein Lawrence Otto CBO & COO | 2020-05-11 | Sale | −24,318 | $60.38 | $1,468,321 | 20,682 | D |
| Klein Lawrence Otto CBO & COO | 2020-05-11 | Sale | −682 | $61.07 | $41,650 | 20,000 | D |
| Derivatives | |||||||
| Klein Lawrence Otto CBO & COO | 2020-05-11 | Option exercise · Stock Option (Right to Buy) | −25,000 | 38,666 | D | ||
| Open-market sales · 25,000 sh · avg $60.40 · $1,509,971 | |||||||
Loading xslF345X03/doc4.xml…